Home / Brands / Teva Pharmaceuticals USA
Teva Pharmaceuticals USA Recalls
279 recalls on record · June 27, 2012 to May 13, 2026 · Drugs
Recalls by year
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
May 13, 2026DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, In Single-Dose kits containing: 8-mL
Hazard: Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
April 29, 2026DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, NDC 0555-1054-56, with 10x10 blister packs
Hazard: Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin
April 15, 2026DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufact
Hazard: CGMP Deviations: use of an unapproved raw material
April 15, 2026DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufact
Hazard: CGMP Deviations: use of an unapproved raw material
April 15, 2026DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx Only, Manufact
Hazard: CGMP Deviations: use of an unapproved raw material
April 15, 2026DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc.
Hazard: Superpotent and Subpotent
April 15, 2026DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufactured for: Teva Pharmaceuticals USA, Inc.
Hazard: Superpotent and Subpotent
April 1, 2026DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, Single-dose 8 mL vial in Kit, Rx onl
Hazard: Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
April 1, 2026DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20 mg, Single-dose 8 mL vial in Kit, Rx onl
Hazard: Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
April 1, 2026DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 10 mg, Single-dose 8 mL vial in Kit, Rx onl
Hazard: Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
March 11, 2026DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, N
Hazard: Failed Dissolution Specifications
March 11, 2026DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bottles (NDC: 45963-677-11) and 1,000 tablet
Hazard: Failed Dissolution Specifications
March 11, 2026DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1,000 tablets bottles
Hazard: Failed Dissolution Specifications
March 11, 2026DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Metoprolol Succinate Extended-Release Tablets, 25 mg, 100 tablets bottles (NDC: 45963-709-11) and 1,000 tablets bottles
Hazard: Failed Dissolution Specifications
December 10, 2025DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose packets, Rx only, Manufactured by: Actavi
Hazard: Defective Container - A defect in the side-seal which allows leakage of product.
November 12, 2025DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx o
Hazard: Subpotent drug; Clavulanate Potassium component
November 5, 2025DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Prazosin Hydrochloride, Capsules, USP, 5 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 194
Hazard: CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.
November 5, 2025DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 194
Hazard: CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.
November 5, 2025DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Prazosin Hydrochloride, Capsules, USP, 1 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 194
Hazard: CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.
July 2, 2025DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb,
Hazard: Presence of foreign tablets/capsules.
February 12, 2025DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Granix (tbo-filgrastim) Injection 300 mcg/0.5 mL, Single Dose prefilled syringe, packaged as a) 1 syringe in 1 CARTON, N
Hazard: Failed Stability Specifications - 12-month stability test result for one of the known peptides is below the specification limit
August 28, 2024DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Testosterone Gel, 1.62%, (Alcohol 80% v/v), 30 unit-dose packets, Rx Only, Teva Pharmaceuticals, USA, Inc. North Wales,
Hazard: Superpotent Drug
July 24, 2024DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 100 Tablets per bottle, Manufactured in Canada By: Patheon, Inc., M
Hazard: Failed Impurities/Degradation Specifications: Product is being recalled due to API related substances and unknown impurities that are above the specification limits.
June 26, 2024DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Amoxicillin and Clavulanate Potassium Tablets USP, Chewable 400mg/57mg, 20-count bottles, Rx only, Manufactured in Canad
Hazard: Subpotent Drug
April 17, 2024DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Isotretinoin Capsules, USP 40mg, 30-count 3x10 blister packs per carton, Rx Only, Manufactured For: Teva Pharmaceutical
Hazard: Superpotent Drug: The 3-month stability result for assay was found to be above specification limit
April 3, 2024DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen, packaged in carton containing 3 Bl
Hazard: Failed Dissolution Specifications
February 21, 2024DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Nortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP- triphasic regimen), packaged in cartons, each carton con
Hazard: Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.
February 21, 2024DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister ca
Hazard: Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.
February 7, 2024DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Budesonide Extended-Release Tablets 9mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort
Hazard: Failed Dissolution Specifications
December 6, 2023DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Testosterone Gel, 1.62% CIII (Alcohol 80% v/v), packaged in 30 unit-dose packets per carton, Rx only, Teva Pharmaceutica
Hazard: OOS for viscosity